Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

Darinaparsin is a novel organic arsenical compound of dimethylated arsenic conjugated to glutathione, with antitumor activity and a mechanism of action markedly different from other available agents. This phase 2, nonrandomized, single-arm, open-label study evaluated the efficacy and safety of intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won-Seog, Fukuhara, Noriko, Yoon, Dok-Hyun, Yamamoto, Kazuhito, Uchida, Toshiki, Negoro, Eiju, Izutsu, Koji, Terui, Yasuhito, Nakajima, Hideaki, Ando, Kiyoshi, Suehiro, Youko, Kang, Hye Jin, Ko, Po-Shen, Nagahama, Fumiko, Sonehara, Yusuke, Nagai, Hirokazu, Tien, Hwei-Fang, Kwong, Yok-Lam, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463191/
https://www.ncbi.nlm.nih.gov/pubmed/36661315
http://dx.doi.org/10.1182/bloodadvances.2022008615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463191/
https://www.ncbi.nlm.nih.gov/pubmed/36661315
http://dx.doi.org/10.1182/bloodadvances.2022008615

Ejemplares similares